DK3288967T3 - Farmaceutisk forbindelse - Google Patents

Farmaceutisk forbindelse Download PDF

Info

Publication number
DK3288967T3
DK3288967T3 DK16729054.3T DK16729054T DK3288967T3 DK 3288967 T3 DK3288967 T3 DK 3288967T3 DK 16729054 T DK16729054 T DK 16729054T DK 3288967 T3 DK3288967 T3 DK 3288967T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical
relationship
pharmaceutical relationship
Prior art date
Application number
DK16729054.3T
Other languages
English (en)
Inventor
Philippe Wolgen
Roland Callens
Original Assignee
Vallaurix Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vallaurix Pte Ltd filed Critical Vallaurix Pte Ltd
Application granted granted Critical
Publication of DK3288967T3 publication Critical patent/DK3288967T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK16729054.3T 2015-04-28 2016-04-28 Farmaceutisk forbindelse DK3288967T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15165537.0A EP3088418A1 (en) 2015-04-28 2015-04-28 Pharmaceutical compound
PCT/IB2016/052416 WO2016174610A1 (en) 2015-04-28 2016-04-28 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
DK3288967T3 true DK3288967T3 (da) 2020-02-10

Family

ID=53016525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16729054.3T DK3288967T3 (da) 2015-04-28 2016-04-28 Farmaceutisk forbindelse

Country Status (14)

Country Link
US (1) US20180086789A1 (da)
EP (2) EP3088418A1 (da)
JP (1) JP6795258B2 (da)
KR (1) KR20180002720A (da)
AU (1) AU2016255690B2 (da)
CA (1) CA2983980A1 (da)
DK (1) DK3288967T3 (da)
ES (1) ES2769253T3 (da)
PH (1) PH12017501979A1 (da)
PL (1) PL3288967T3 (da)
PT (1) PT3288967T (da)
SG (1) SG11201708818VA (da)
SI (1) SI3288967T1 (da)
WO (1) WO2016174610A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088417A1 (en) * 2015-04-28 2016-11-02 Vallaurix Pte. Ltd. Pharmaceutical compound
ES2985745T3 (es) * 2017-02-01 2024-11-07 Vallaurix Mc S A R L Análogos de alfa-MSH utilizados en el tratamiento de Xeroderma Pigmentosum
WO2025253347A1 (en) 2024-06-07 2025-12-11 Vimela Therapeutics, Inc. Topical delivery of melanocortin-1 receptor agonists formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
CA2575866C (en) 2004-08-04 2018-07-10 Clinuvel Pharmaceuticals Limited Methods for inducing melanogenesis in a subject
PL2056855T3 (pl) 2006-08-31 2015-04-30 Clinuvel Pharmaceuticals Ltd Pochodne alfa-MSH do leczenia fotodermatoz
EP2487185A1 (en) 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
GB201310921D0 (en) * 2013-06-19 2013-07-31 Chemical & Biopharmaceutical Lab Of Patras S A Peptide-resin conjugate and use thereof

Also Published As

Publication number Publication date
WO2016174610A1 (en) 2016-11-03
EP3088418A1 (en) 2016-11-02
EP3288967B1 (en) 2019-11-06
JP6795258B2 (ja) 2020-12-02
ES2769253T3 (es) 2020-06-25
JP2018515600A (ja) 2018-06-14
PT3288967T (pt) 2020-02-04
SG11201708818VA (en) 2017-11-29
PH12017501979A1 (en) 2018-03-26
PL3288967T3 (pl) 2020-05-18
CA2983980A1 (en) 2016-11-03
EP3288967A1 (en) 2018-03-07
US20180086789A1 (en) 2018-03-29
SI3288967T1 (sl) 2020-04-30
AU2016255690A1 (en) 2017-12-07
KR20180002720A (ko) 2018-01-08
AU2016255690B2 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
SI3529248T1 (sl) Farmacevtske spojine
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3265421T3 (da) Doseringssystem
DK3277719T3 (da) Polypeptider
PT4070788T (pt) Formulações farmacêuticas
IL254818A0 (en) Ribociclib tablet
DK3199161T3 (da) Farmaceutisk præparat
DK3529240T3 (da) Farmaceutiske forbindelser
EP3424940A4 (en) Radiolabeled drug
DK3270930T3 (da) Præeklampsi
DK3463345T3 (da) Farmaceutiske kombinationer
EP3246047C0 (en) COMBINATION MEDICATION
PT3200772T (pt) Composições farmacêuticas compreendendo alpelisib
EP3437644A4 (en) MEDICINE
DK3274482T3 (da) Stenborsknop
KR20180084810A (ko) 정제 세트
DE112015006486A5 (de) Inkubationsrinne
EP3527216A4 (en) MEDICINE
DK3280447T3 (da) Farmaceutiske formuleringer
EP3334447A4 (en) CCK2R-drug conjugates
DE102015206660A8 (de) Plattenaufteilanlage
DE112015005905A5 (de) Gurtschlossbringer
EP3395344A4 (en) MEDICINE
DE112016005599A5 (de) Strahlungsgrill
HUE050881T2 (hu) Gyógyszerkészítmény